Form 4: Hims & Hers CFO Executes Stock Option Exercises and Sales Under 10b5-1 Plan
SEC Form 4 Filing
Hims & Hers Health, Inc. CFO, Oluyemi Okupe, executed stock option exercises and sales of Class A Common Stock under a pre-arranged 10b5-1 trading plan.
Summary
- Oluyemi Okupe, the Chief Financial Officer of Hims & Hers Health, Inc., engaged in multiple transactions involving the company's Class A Common Stock on November 13, 2024.
- These transactions included the exercise of stock options to acquire 26,100 shares at $11.53 per share and 83,209 shares at $5.01 per share.
- Following the exercises, Okupe sold a total of 143,789 shares of Class A Common Stock at prices ranging from $28.10 to $30.42 per share.
- The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on May 31, 2024.
- After these transactions, Okupe directly owns 112,186 shares of Class A Common Stock.
Sentiment
Score: 5
Explanation: The document is a routine SEC filing detailing stock transactions by an executive. It doesn't indicate any positive or negative sentiment, it is a neutral report of transactions.
Industry Context
This is a routine filing for insider transactions and is common for executives who have stock options as part of their compensation. The use of a 10b5-1 plan indicates a pre-planned strategy for these transactions.
Comparison to Industry Standards
- The use of a 10b5-1 trading plan is a common practice among executives at publicly traded companies to avoid accusations of insider trading.
- The vesting schedules for the stock options are typical for executive compensation packages, often including both monthly and annual vesting components.
- The price range of the stock sales is within the normal trading range for the company's stock on the transaction date.
Stakeholder Impact
- The transactions may have a minor impact on the stock price due to the volume of shares sold by the CFO.
- The use of a 10b5-1 plan provides transparency and reduces the risk of insider trading concerns for shareholders.
Key Dates
| Date | Description |
|---|---|
| 01/24/2022 | Vesting Commencement Date for some stock options. |
| 04/01/2023 | Start date for monthly vesting of some stock options. |
| 05/31/2024 | Date the Rule 10b5-1 trading plan was adopted. |
| 11/13/2024 | Date of stock option exercises and sales. |
| 11/14/2024 | Date of filing the SEC Form 4. |
| 02/23/2032 | Expiration date for some stock options. |
| 03/01/2033 | Expiration date for some stock options. |
Keywords
stock options, Rule 10b5-1, insider trading, Class A Common Stock, SEC Form 4, Hims & Hers Health, Oluyemi Okupe, CFO, stock sale
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.